151 related articles for article (PubMed ID: 31641101)
1. The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.
Di Maira G; Gentilini A; Pastore M; Caligiuri A; Piombanti B; Raggi C; Rovida E; Lewinska M; Andersen JB; Borgo C; Salvi M; Ottaviani D; Ruzzene M; Marra F
Oncogenesis; 2019 Oct; 8(11):61. PubMed ID: 31641101
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.
Lustri AM; Di Matteo S; Fraveto A; Costantini D; Cantafora A; Napoletano C; Bragazzi MC; Giuliante F; De Rose AM; Berloco PB; Grazi GL; Carpino G; Alvaro D
PLoS One; 2017; 12(9):e0183932. PubMed ID: 28873435
[TBL] [Abstract][Full Text] [Related]
3. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
4. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
Lebrin F; Chambaz EM; Bianchini L
Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells.
Zonta F; Borgo C; Quezada Meza CP; Masgras I; Rasola A; Salvi M; Pinna LA; Ruzzene M
Cells; 2021 Jan; 10(1):. PubMed ID: 33477590
[TBL] [Abstract][Full Text] [Related]
6. Targeting protein kinase CK2 in the treatment of cholangiocarcinoma.
Jayaraman PS; Gaston K
Explor Target Antitumor Ther; 2021; 2(5):434-447. PubMed ID: 36045705
[TBL] [Abstract][Full Text] [Related]
7. The activity of CK2 in the extracts of COS-7 cells transfected with wild type and mutant subunits of protein kinase CK2.
Korn I; Jacob G; Allende CC; Allende JE
Mol Cell Biochem; 2001 Nov; 227(1-2):37-44. PubMed ID: 11827173
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
9. Generation and quantitative proteomics analysis of CK2α/α'
Borgo C; Franchin C; Scalco S; Bosello-Travain V; Donella-Deana A; Arrigoni G; Salvi M; Pinna LA
Sci Rep; 2017 Feb; 7():42409. PubMed ID: 28209983
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the phosphoproteome of CK2
Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
Open Biol; 2023 Feb; 13(2):220220. PubMed ID: 36809799
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons.
Lettieri A; Borgo C; Zanieri L; D'Amore C; Oleari R; Paganoni A; Pinna LA; Cariboni A; Salvi M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779225
[TBL] [Abstract][Full Text] [Related]
12. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.
Lertsuwan J; Lertsuwan K; Sawasdichai A; Tasnawijitwong N; Lee KY; Kitchen P; Afford S; Gaston K; Jayaraman PS; Satayavivad J
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30142881
[TBL] [Abstract][Full Text] [Related]
13. Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.
Faust M; Jung M; Günther J; Zimmermann R; Montenarh M
Mol Cell Biochem; 2001 Nov; 227(1-2):73-80. PubMed ID: 11827177
[TBL] [Abstract][Full Text] [Related]
14. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
15. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.
Loilome W; Juntana S; Namwat N; Bhudhisawasdi V; Puapairoj A; Sripa B; Miwa M; Saya H; Riggins GJ; Yongvanit P
Int J Cancer; 2011 Jul; 129(1):34-44. PubMed ID: 20824711
[TBL] [Abstract][Full Text] [Related]
16. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
17. A proteomics analysis of CK2β
Borgo C; Franchin C; Cesaro L; Zaramella S; Arrigoni G; Salvi M; Pinna LA
FEBS J; 2019 Apr; 286(8):1561-1575. PubMed ID: 30834696
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.
Franchin C; Borgo C; Cesaro L; Zaramella S; Vilardell J; Salvi M; Arrigoni G; Pinna LA
Cell Mol Life Sci; 2018 Jun; 75(11):2011-2026. PubMed ID: 29119230
[TBL] [Abstract][Full Text] [Related]
19. In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.
Bestgen B; Belaid-Choucair Z; Lomberget T; Le Borgne M; Filhol O; Cochet C
Pharmaceuticals (Basel); 2017 Feb; 10(1):. PubMed ID: 28165359
[TBL] [Abstract][Full Text] [Related]
20. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
